Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Asensus Surgical Inc (ASXC) USD0.001

Sell:$1.94 Buy:$1.97 Change: $0.02 (1.02%)
Market closed |  Prices as at close on 16 September 2021 | Switch to live prices |
Sell:$1.94
Buy:$1.97
Change: $0.02 (1.02%)
Market closed |  Prices as at close on 16 September 2021 | Switch to live prices |
Sell:$1.94
Buy:$1.97
Change: $0.02 (1.02%)
Market closed |  Prices as at close on 16 September 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Asensus Surgical, Inc., formerly TransEnterix, Inc., is a medical device company. The Company is engaged in digitizing the interface between the surgeon and the patient to improve minimally invasive surgery (MIS) through digital laparoscopy. The Senhance system is a machine vision system for use in robotic surgery, which is powered by intelligent surgical unit that enables augmented intelligence in surgery. Its System is designed to maintain laparoscopic MIS standards while providing digital benefits such as haptic feedback, advanced instrumentation, including three-millimeter micro laparoscopic instruments, eye-sensing camera control and reusable standard instruments to patients around the world. The Senhance System is used in Europe for laparoscopic abdominal and pelvic surgery, as well as limited thoracic operations. It is also available in the United States, Japan, Taiwan and Russia.

Contact details

Address:
1 TW ALEXANDER DRIVE, SUITE 160
DURHAM
27703
United States
Telephone:
+1 (919) 7658400
Website:
https://asensus.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ASXC
ISIN:
US04367G1031
Market cap:
$454.59 million
Shares in issue:
234.32 million
Sector:
Health Care Equipment
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Anthony Fernando
    President, Chief Executive Officer, Director
  • Shameze Rampertab
    Chief Financial Officer, Executive Vice President

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.